1
|
Currie G, Hewis J, Ebbs P. Gender bias in text-to-image generative artificial intelligence depiction of Australian paramedics and first responders. Australas Emerg Care 2025; 28:103-109. [PMID: 39627045 DOI: 10.1016/j.auec.2024.11.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2024] [Revised: 11/24/2024] [Accepted: 11/24/2024] [Indexed: 05/16/2025]
Abstract
INTRODUCTION In Australia, almost 50 % of paramedics are female yet they remain under-represented in stereotypical depictions of the profession. The potentially transformative value of generative artificial intelligence (AI) may be limited by stereotypical errors, misrepresentations and bias. Increasing use of text-to-image generative AI, like DALL-E 3, could reinforce gender and ethnicity biases and, therefore, is important to objectively evaluate. METHOD In March 2024, DALL-E 3 was utilised via GPT-4 to generate a series of individual and group images of Australian paramedics, ambulance officers, police officers and firefighters. In total, 82 images were produced including 60 individual-character images, and 22 multiple-character group images. All 326 depicted characters were independently analysed by three reviewers for apparent gender, age, skin tone and ethnicity. RESULTS Among first responders, 90.8 % (N = 296) were depicted as male, 90.5 % (N = 295) as Caucasian, 95.7 % (N = 312) as a light skin tone, and 94.8 % (N = 309) as under 55 years of age. For paramedics and police the gender distribution was a statistically significant variation from that of actual Australian workforce data (all p < 0.001). Among the images of individual paramedics and ambulance officers (N = 32), DALL-E 3 depicted 100 % as male, 100 % as Caucasian and 100 % with light skin tone. CONCLUSION Gender and ethnicity bias is a significant limitation for text-to-image generative AI using DALL-E 3 among Australian first responders. Generated images have a disproportionately high misrepresentation of males, Caucasians and light skin tones that are not representative of the diversity of paramedics in Australia today.
Collapse
Affiliation(s)
- Geoffrey Currie
- Charles Sturt University, Wagga Wagga, Australia; Baylor College of Medicine, Houston, USA.
| | | | - Phillip Ebbs
- Charles Sturt University, Port Macquarie, Australia
| |
Collapse
|
2
|
Hawk KE, Currie GM. Artificial Intelligence and Workforce Diversity in Nuclear Medicine. Semin Nucl Med 2025; 55:437-449. [PMID: 39567337 DOI: 10.1053/j.semnuclmed.2024.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2024] [Accepted: 10/07/2024] [Indexed: 11/22/2024]
Abstract
Artificial intelligence (AI) has rapidly reshaped the global practice of nuclear medicine. Through this shift, the integration of AI into nuclear medicine education, clinical practice, and research has a significant impact on workforce diversity. While AI in nuclear medicine has the potential to be a powerful tool to improve clinical, research and educational practice, and to enhance patient care, careful examination of the impact of each AI tool needs to be undertaken with respect to the impact on, among other factors, diversity in the nuclear medicine workforce. Some AI tools can be used to specifically drive inclusivity and diversity of the workforce by supporting women and underrepresented minorities. Other tools, however, have the potential to negatively impact minority groups, leading to a widening of the diversity gap. This manuscript explores how various AI solutions have the potential to both negatively and positively affect diversity in the nuclear medicine workforce.
Collapse
Affiliation(s)
- K Elizabeth Hawk
- Charles Sturt University, Wagga Wagga, NSW, Australia; Stanford University, Stanford, CA
| | | |
Collapse
|
3
|
Currie GM, Hawk KE, Rohren EM. Generative Artificial Intelligence Biases, Limitations and Risks in Nuclear Medicine: An Argument for Appropriate Use Framework and Recommendations. Semin Nucl Med 2025; 55:423-436. [PMID: 38851934 DOI: 10.1053/j.semnuclmed.2024.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2024] [Accepted: 05/16/2024] [Indexed: 06/10/2024]
Abstract
Generative artificial intelligence (AI) algorithms for both text-to-text and text-to-image applications have seen rapid and widespread adoption in the general and medical communities. While limitations of generative AI have been widely reported, there remain valuable applications in patient and professional communities. Here, the limitations and biases of both text-to-text and text-to-image generative AI are explored using purported applications in medical imaging as case examples. A direct comparison of the capabilities of four common text-to-image generative AI algorithms is reported and recommendations for the most appropriate use, DALL-E 3, justified. The risks use and biases are outlined, and appropriate use guidelines framed for use of generative AI in nuclear medicine. Generative AI text-to-text and text-to-image generation includes inherent biases, particularly gender and ethnicity, that could misrepresent nuclear medicine. The assimilation of generative AI tools into medical education, image interpretation, patient education, health promotion and marketing in nuclear medicine risks propagating errors and amplification of biases. Mitigation strategies should reside inside appropriate use criteria and minimum standards for quality and professionalism for the application of generative AI in nuclear medicine.
Collapse
Affiliation(s)
- Geoffrey M Currie
- School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, Australia; Dept of Radiology, Baylor College of Medicine, Houston.
| | - K Elizabeth Hawk
- School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, Australia; Dept of Radiology, Stanford University, Stanford
| | - Eric M Rohren
- School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, Australia; Dept of Radiology, Baylor College of Medicine, Houston
| |
Collapse
|
4
|
Currie G. Molecular theranostics: principles, challenges and controversies. J Med Radiat Sci 2025; 72:156-164. [PMID: 39485717 PMCID: PMC11909690 DOI: 10.1002/jmrs.836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2024] [Accepted: 10/19/2024] [Indexed: 11/03/2024] Open
Abstract
Theranostics is a new term for long-established principles in nuclear medicine. The generalisability of the term means there is a very broad use of the term across the medical literature, not all of which is consistent with the intent in nuclear medicine. The term molecular theranostics better reflects the philosophy and application in nuclear medicine. Even with a clearer definition, there are a number of challenges or controversies whose debate provides a richer understanding of the principles and applications of molecular theranostics. Radioiodine imaging and therapy of hyperthyroidism and thyroid cancer provide the historical context for theranostics. The prototype molecular theranostic is the 68Ga/177Lu DOTATATE pair that targets somatostatin receptor subtype 2 in neuroendocrine tumors. The potential value of precision medicine of radiation dosimetry in molecular theranostics needs a balanced discussion with limitations of reactive dosimetry and the opportunities for predictive or pre-treatment dosimetry. Despite challenges and limitations, molecular theranostics is a powerful tool in the precision medicine landscape. Molecular theranostics is a vehicle for improved outcomes in cancer patients with a future-facing portfolio of opportunities.
Collapse
|
5
|
Currie GM, Rohren EM. Sharpening the Blade of Precision Theranostics. Semin Nucl Med 2025:S0001-2998(25)00007-8. [PMID: 40000269 DOI: 10.1053/j.semnuclmed.2025.01.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2025] [Revised: 01/23/2025] [Accepted: 01/24/2025] [Indexed: 02/27/2025]
Abstract
While theranostics is a new term for long-standing principles in nuclear medicine, recent advances have facilitated more personalized healthcare and precision medicine. Despite the widespread enthusiasm for theranostics and well established and standardized procedures, there are a number of opportunities to enhance practice and sharpen the blade of precision theranostics. A clear understanding of the requisites of an authentic theranostic pair reveals limitations in current approaches. Indeed, standardized dosing regimes based on activity dose as opposed to absorbed dose highlight the potential enhancements to outcomes and precision medicine that predictive dosimetry could bring. Such advances increase the demand for closer matching of biological and chemical properties of theranostic pairs. In turn, the need for more authentic or true theranostic pairs is revealed. While theranostics has provided a revolutionary toolkit for cancer management, advances in instrumentation, radiochemistry or clinical domains requires similar advances in the remaining domains. This discussion explores key considerations for an evolving theranostics landscape, recognising current best practice may fall short of precision medicine over coming years.
Collapse
Affiliation(s)
- Geoffrey M Currie
- Charles Sturt University, New South Wales, Australia; Baylor College of Medicine, TX, USA.
| | - Eric M Rohren
- Charles Sturt University, New South Wales, Australia; Baylor College of Medicine, TX, USA
| |
Collapse
|
6
|
Kahraman F, Aktas A, Bayrakceken S, Çakar T, Tarcan HS, Bayram B, Durak B, Ulman YI. Physicians' ethical concerns about artificial intelligence in medicine: a qualitative study: "The final decision should rest with a human". Front Public Health 2024; 12:1428396. [PMID: 39664534 PMCID: PMC11631923 DOI: 10.3389/fpubh.2024.1428396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Accepted: 11/06/2024] [Indexed: 12/13/2024] Open
Abstract
Background/aim Artificial Intelligence (AI) is the capability of computational systems to perform tasks that require human-like cognitive functions, such as reasoning, learning, and decision-making. Unlike human intelligence, AI does not involve sentience or consciousness but focuses on data processing, pattern recognition, and prediction through algorithms and learned experiences. In healthcare including neuroscience, AI is valuable for improving prevention, diagnosis, prognosis, and surveillance. Methods This qualitative study aimed to investigate the acceptability of AI in Medicine (AIIM) and to elucidate any technical and scientific, as well as social and ethical issues involved. Twenty-five doctors from various specialties were carefully interviewed regarding their views, experience, knowledge, and attitude toward AI in healthcare. Results Content analysis confirmed the key ethical principles involved: confidentiality, beneficence, and non-maleficence. Honesty was the least invoked principle. A thematic analysis established four salient topic areas, i.e., advantages, risks, restrictions, and precautions. Alongside the advantages, there were many limitations and risks. The study revealed a perceived need for precautions to be embedded in healthcare policies to counter the risks discussed. These precautions need to be multi-dimensional. Conclusion The authors conclude that AI should be rationally guided, function transparently, and produce impartial results. It should assist human healthcare professionals collaboratively. This kind of AI will permit fairer, more innovative healthcare which benefits patients and society whilst preserving human dignity. It can foster accuracy and precision in medical practice and reduce the workload by assisting physicians during clinical tasks. AIIM that functions transparently and respects the public interest can be an inspiring scientific innovation for humanity.
Collapse
Affiliation(s)
- Fatma Kahraman
- Acibadem University, Departmant of Psychology, Istanbul, Türkiye
| | - Aysenur Aktas
- Acibadem University, Departmant of Psychology, Istanbul, Türkiye
| | | | - Tuna Çakar
- MEF University, Department of Computer Engineering, Istanbul, Türkiye
| | | | - Bugrahan Bayram
- Acibadem University, Biomedical Engineering Department, Istanbul, Türkiye
| | - Berk Durak
- Acibadem University, School of Medicine, Istanbul, Türkiye
| | - Yesim Isil Ulman
- Acibadem University School of Medicine, History of Medicine and Ethics Department, Istanbul, Türkiye
| |
Collapse
|
7
|
Currie G, John G, Hewis J. Gender and ethnicity bias in generative artificial intelligence text-to-image depiction of pharmacists. INTERNATIONAL JOURNAL OF PHARMACY PRACTICE 2024; 32:524-531. [PMID: 39228085 DOI: 10.1093/ijpp/riae049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2024] [Accepted: 08/15/2024] [Indexed: 09/05/2024]
Abstract
INTRODUCTION In Australia, 64% of pharmacists are women but continue to be under-represented. Generative artificial intelligence (AI) is potentially transformative but also has the potential for errors, misrepresentations, and bias. Generative AI text-to-image production using DALL-E 3 (OpenAI) is readily accessible and user-friendly but may reinforce gender and ethnicity biases. METHODS In March 2024, DALL-E 3 was utilized to generate individual and group images of Australian pharmacists. Collectively, 40 images were produced with DALL-E 3 for evaluation of which 30 were individual characters and the remaining 10 images were comprised of multiple characters (N = 155). All images were independently analysed by two reviewers for apparent gender, age, ethnicity, skin tone, and body habitus. Discrepancies in responses were resolved by third-observer consensus. RESULTS Collectively for DALL-E 3, 69.7% of pharmacists were depicted as men, 29.7% as women, 93.5% as a light skin tone, 6.5% as mid skin tone, and 0% as dark skin tone. The gender distribution was a statistically significant variation from that of actual Australian pharmacists (P < .001). Among the images of individual pharmacists, DALL-E 3 generated 100% as men and 100% were light skin tone. CONCLUSIONS This evaluation reveals the gender and ethnicity bias associated with generative AI text-to-image generation using DALL-E 3 among Australian pharmacists. Generated images have a disproportionately high representation of white men as pharmacists which is not representative of the diversity of pharmacists in Australia today.
Collapse
Affiliation(s)
- Geoffrey Currie
- School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, Australia
- Department of Radiology, Baylor College of Medicine, Houston, United States
| | - George John
- School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, Australia
| | - Johnathan Hewis
- School of Dentistry and Medical Sciences, Charles Sturt University, Port Macquarie, Australia
| |
Collapse
|
8
|
Yu L, Zhai X. Use of artificial intelligence to address health disparities in low- and middle-income countries: a thematic analysis of ethical issues. Public Health 2024; 234:77-83. [PMID: 38964129 DOI: 10.1016/j.puhe.2024.05.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Revised: 04/26/2024] [Accepted: 05/22/2024] [Indexed: 07/06/2024]
Abstract
OBJECTIVES Artificial intelligence (AI) is reshaping health and medicine, especially through its potential to address health disparities in low- and middle-income countries (LMICs). However, there are several issues associated with the use of AI that may reduce its impact and potentially exacerbate global health disparities. This study presents the key issues in AI deployment faced by LMICs. STUDY DESIGN Thematic analysis. METHODS PubMed, Scopus, Embase and the Web of Science databases were searched, from the date of their inception until September 2023, using the terms "artificial intelligence", "LMICs", "ethic∗" and "global health". Additional searches were conducted by snowballing references before and after the primary search. The final studies were chosen based on their relevance to the topic of this article. RESULTS After reviewing 378 articles, 14 studies were included in the final analysis. A concept named the 'AI Deployment Paradox' was introduced to focus on the challenges of using AI to address health disparities in LMICs, and the following three categories were identified: (1) data poverty and contextual shifts; (2) cost-effectiveness and health equity; and (3) new technological colonisation and potential exploitation. CONCLUSIONS The relationship between global health, AI and ethical considerations is an area that requires systematic investigation. Relying on health data inherent with structural biases and deploying AI without systematic ethical considerations may exacerbate global health inequalities. Addressing these challenges requires nuanced socio-political comprehension, localised stakeholder engagement, and well-considered ethical and regulatory frameworks.
Collapse
Affiliation(s)
- Lanyi Yu
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Center for Bioethics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - Xiaomei Zhai
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Center for Bioethics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
| |
Collapse
|
9
|
Murali S, Ding H, Adedeji F, Qin C, Obungoloch J, Asllani I, Anazodo U, Ntusi NAB, Mammen R, Niendorf T, Adeleke S. Bringing MRI to low- and middle-income countries: Directions, challenges and potential solutions. NMR IN BIOMEDICINE 2024; 37:e4992. [PMID: 37401341 DOI: 10.1002/nbm.4992] [Citation(s) in RCA: 16] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/20/2022] [Revised: 05/27/2023] [Accepted: 05/30/2023] [Indexed: 07/05/2023]
Abstract
The global disparity of magnetic resonance imaging (MRI) is a major challenge, with many low- and middle-income countries (LMICs) experiencing limited access to MRI. The reasons for limited access are technological, economic and social. With the advancement of MRI technology, we explore why these challenges still prevail, highlighting the importance of MRI as the epidemiology of disease changes in LMICs. In this paper, we establish a framework to develop MRI with these challenges in mind and discuss the different aspects of MRI development, including maximising image quality using cost-effective components, integrating local technology and infrastructure and implementing sustainable practices. We also highlight the current solutions-including teleradiology, artificial intelligence and doctor and patient education strategies-and how these might be further improved to achieve greater access to MRI.
Collapse
Affiliation(s)
- Sanjana Murali
- School of Medicine, Faculty of Medicine, Imperial College London, London, UK
| | - Hao Ding
- School of Medicine, Faculty of Medicine, Imperial College London, London, UK
| | - Fope Adedeji
- School of Medicine, Faculty of Medicine, University College London, London, UK
| | - Cathy Qin
- Department of Imaging, Imperial College Healthcare NHS Trust, London, UK
| | - Johnes Obungoloch
- Department of Biomedical Engineering, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Iris Asllani
- Department of Biomedical Engineering, Rochester Institute of Technology, Rochester, New York, USA
| | - Udunna Anazodo
- Department of Medical Biophysics, Western University, London, Ontario, Canada
- The Research Institute of London Health Sciences Centre and St. Joseph's Health Care, London, Ontario, Canada
| | - Ntobeko A B Ntusi
- Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
- South African Medical Research Council Extramural Unit on Intersection of Noncommunicable Diseases and Infectious Diseases, Cape Town, South Africa
| | - Regina Mammen
- Department of Cardiology, The Essex Cardiothoracic Centre, Basildon, UK
| | - Thoralf Niendorf
- Berlin Ultrahigh Field Facility (BUFF), Max-Delbrück Centre for Molecular Medicine in the Helmholtz Association, Berlin, Germany
| | - Sola Adeleke
- School of Cancer & Pharmaceutical Sciences, King's College London, London, UK
- High Dimensional Neuro-oncology, University College London Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK
| |
Collapse
|
10
|
Hoagland A, Kipping S. Challenges in Promoting Health Equity and Reducing Disparities in Access Across New and Established Technologies. Can J Cardiol 2024; 40:1154-1167. [PMID: 38417572 DOI: 10.1016/j.cjca.2024.02.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Revised: 02/20/2024] [Accepted: 02/21/2024] [Indexed: 03/01/2024] Open
Abstract
Medical innovations and novel technologies stand to improve the return on high levels of health spending in developed countries, particularly in cardiovascular care. However, cardiac innovations also disrupt the landscape of accessing care, potentially creating disparities in who has access to novel and extant technologies. These disparities might disproportionately harm vulnerable groups, including those whose nonmedical conditions-including social determinants of health-inhibit timely access to diagnoses, referrals, and interventions. We first document the barriers to access novel and existing technologies in isolation, then proceed to document their interaction. Novel cardiac technologies might affect existing available services, and change the landscape of care for vulnerable patient groups who seek access to cardiology services. There is a clear need to identify and heed lessons learned from the dissemination of past innovations in the development, funding, and dissemination of future medical technologies to promote equitable access to cardiovascular care. We conclude by highlighting and synthesizing several policy implications from recent literature.
Collapse
Affiliation(s)
- Alex Hoagland
- Institute of Health Policy, Management, and Evaluation, University of Toronto, Ontario Shores Centre for Mental Health Sciences, Toronto, Ontario, Canada.
| | - Sarah Kipping
- Institute of Health Policy, Management, and Evaluation, University of Toronto, Ontario Shores Centre for Mental Health Sciences, Toronto, Ontario, Canada
| |
Collapse
|
11
|
Currie GM, Hawk KE, Rohren EM. The potential role of artificial intelligence in sustainability of nuclear medicine. Radiography (Lond) 2024; 30 Suppl 1:119-124. [PMID: 38582701 DOI: 10.1016/j.radi.2024.03.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2024] [Revised: 03/08/2024] [Accepted: 03/12/2024] [Indexed: 04/08/2024]
Affiliation(s)
- G M Currie
- Charles Sturt University, NSW, Australia; Baylor College of Medicine, Texas, USA.
| | - K E Hawk
- University of California San Diego, California, USA; Stanford University, California, USA
| | - E M Rohren
- Charles Sturt University, NSW, Australia; Baylor College of Medicine, Texas, USA
| |
Collapse
|
12
|
Currie GM, Hawk KE, Rohren EM. Challenges confronting sustainability in nuclear medicine practice. Radiography (Lond) 2024; 30 Suppl 1:1-8. [PMID: 38797115 DOI: 10.1016/j.radi.2024.04.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2024] [Revised: 04/23/2024] [Accepted: 04/26/2024] [Indexed: 05/29/2024]
Abstract
BACKGROUND Sustainability can be defined as the state in which consumption or depletion do not exceed regeneration. It can further be considered in five dimensions: environmental, economic, social, human resources, and ecological. KEY FINDINGS There are a number of key issues that threaten sustainability across nuclear medicine clinical and research practices, and across the five dimensions of sustainability there is a requirement for compromise between conflicting priorities. Nonetheless, the field of nuclear medicine benefits from an inherent culture of innovation and forethought which fosters adaptation in order to achieve sustainability. CONCLUSION The principles of sustainability are particularly challenging to navigate due to resource scarcity in nuclear medicine associated with both workforce shortages and supply disruptions. Specific challenges and adaptations are outlined for each of the five dimensions of sustainability. IMPLICATIONS FOR PRACTICE There are opportunities for improving sustainability of nuclear medicine practice although success is reliant on a deeper understanding of the interplay across the five dimensions of sustainability.
Collapse
Affiliation(s)
- G M Currie
- Charles Sturt University, NSW, Australia; Baylor College of Medicine, Texas, USA.
| | - K E Hawk
- Stanford University, California, USA
| | - E M Rohren
- Charles Sturt University, NSW, Australia; Baylor College of Medicine, Texas, USA
| |
Collapse
|
13
|
Fuchs T, Kaiser L, Müller D, Papp L, Fischer R, Tran-Gia J. Enhancing Interoperability and Harmonisation of Nuclear Medicine Image Data and Associated Clinical Data. Nuklearmedizin 2023; 62:389-398. [PMID: 37907246 PMCID: PMC10689089 DOI: 10.1055/a-2187-5701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 09/21/2023] [Indexed: 11/02/2023]
Abstract
Nuclear imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) in combination with computed tomography (CT) are established imaging modalities in clinical practice, particularly for oncological problems. Due to a multitude of manufacturers, different measurement protocols, local demographic or clinical workflow variations as well as various available reconstruction and analysis software, very heterogeneous datasets are generated. This review article examines the current state of interoperability and harmonisation of image data and related clinical data in the field of nuclear medicine. Various approaches and standards to improve data compatibility and integration are discussed. These include, for example, structured clinical history, standardisation of image acquisition and reconstruction as well as standardised preparation of image data for evaluation. Approaches to improve data acquisition, storage and analysis will be presented. Furthermore, approaches are presented to prepare the datasets in such a way that they become usable for projects applying artificial intelligence (AI) (machine learning, deep learning, etc.). This review article concludes with an outlook on future developments and trends related to AI in nuclear medicine, including a brief research of commercial solutions.
Collapse
Affiliation(s)
- Timo Fuchs
- Medical Data Integration Center (MEDIZUKR), University Hospital Regensburg, Regensburg, Germany
- Partner Site Regensburg, Bavarian Center for Cancer Research (BZKF), Regensburg, Germany
| | - Lena Kaiser
- Department of Nuclear Medicine, LMU University Hospital, LMU, Munich, Germany
| | - Dominik Müller
- IT-Infrastructure for Translational Medical Research, University of Augsburg, Augsburg, Germany
- Medical Data Integration Center, University Hospital Augsburg, Augsburg, Germany
| | - Laszlo Papp
- Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Wien, Austria
| | - Regina Fischer
- Medical Data Integration Center (MEDIZUKR), University Hospital Regensburg, Regensburg, Germany
- Partner Site Regensburg, Bavarian Center for Cancer Research (BZKF), Regensburg, Germany
| | - Johannes Tran-Gia
- Department of Nuclear Medicine, University Hospital Würzburg, Wurzburg, Germany
| |
Collapse
|
14
|
Li LT, Haley LC, Boyd AK, Bernstam EV. Technical/Algorithm, Stakeholder, and Society (TASS) barriers to the application of artificial intelligence in medicine: A systematic review. J Biomed Inform 2023; 147:104531. [PMID: 37884177 DOI: 10.1016/j.jbi.2023.104531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 09/14/2023] [Accepted: 10/22/2023] [Indexed: 10/28/2023]
Abstract
INTRODUCTION The use of artificial intelligence (AI), particularly machine learning and predictive analytics, has shown great promise in health care. Despite its strong potential, there has been limited use in health care settings. In this systematic review, we aim to determine the main barriers to successful implementation of AI in healthcare and discuss potential ways to overcome these challenges. METHODS We conducted a literature search in PubMed (1/1/2001-1/1/2023). The search was restricted to publications in the English language, and human study subjects. We excluded articles that did not discuss AI, machine learning, predictive analytics, and barriers to the use of these techniques in health care. Using grounded theory methodology, we abstracted concepts to identify major barriers to AI use in medicine. RESULTS We identified a total of 2,382 articles. After reviewing the 306 included papers, we developed 19 major themes, which we categorized into three levels: the Technical/Algorithm, Stakeholder, and Social levels (TASS). These themes included: Lack of Explainability, Need for Validation Protocols, Need for Standards for Interoperability, Need for Reporting Guidelines, Need for Standardization of Performance Metrics, Lack of Plan for Updating Algorithm, Job Loss, Skills Loss, Workflow Challenges, Loss of Patient Autonomy and Consent, Disturbing the Patient-Clinician Relationship, Lack of Trust in AI, Logistical Challenges, Lack of strategic plan, Lack of Cost-effectiveness Analysis and Proof of Efficacy, Privacy, Liability, Bias and Social Justice, and Education. CONCLUSION We identified 19 major barriers to the use of AI in healthcare and categorized them into three levels: the Technical/Algorithm, Stakeholder, and Social levels (TASS). Future studies should expand on barriers in pediatric care and focus on developing clearly defined protocols to overcome these barriers.
Collapse
Affiliation(s)
- Linda T Li
- Department of Surgery, Division of Pediatric Surgery, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, United States; McWilliams School of Biomedical Informatics at UT Health Houston, 7000 Fannin St, Suite 600, Houston, TX 77030, United States.
| | - Lauren C Haley
- McGovern Medical School at the University of Texas Health Science Center at Houston, 6431 Fannin St, Houston, TX 77030, United States.
| | - Alexandra K Boyd
- McGovern Medical School at the University of Texas Health Science Center at Houston, 6431 Fannin St, Houston, TX 77030, United States.
| | - Elmer V Bernstam
- McWilliams School of Biomedical Informatics at UT Health Houston, 7000 Fannin St, Suite 600, Houston, TX 77030, United States; McGovern Medical School at the University of Texas Health Science Center at Houston, 6431 Fannin St, Houston, TX 77030, United States.
| |
Collapse
|
15
|
Currie GM. Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy? Semin Nucl Med 2023; 53:719-730. [PMID: 37225599 DOI: 10.1053/j.semnuclmed.2023.04.008] [Citation(s) in RCA: 41] [Impact Index Per Article: 20.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2023] [Accepted: 04/30/2023] [Indexed: 05/26/2023]
Abstract
Academic integrity in both higher education and scientific writing has been challenged by developments in artificial intelligence. The limitations associated with algorithms have been largely overcome by the recently released ChatGPT; a chatbot powered by GPT-3.5 capable of producing accurate and human-like responses to questions in real-time. Despite the potential benefits, ChatGPT confronts significant limitations to its usefulness in nuclear medicine and radiology. Most notably, ChatGPT is prone to errors and fabrication of information which poses a risk to professionalism, ethics and integrity. These limitations simultaneously undermine the value of ChatGPT to the user by not producing outcomes at the expected standard. Nonetheless, there are a number of exciting applications of ChatGPT in nuclear medicine across education, clinical and research sectors. Assimilation of ChatGPT into practice requires redefining of norms, and re-engineering of information expectations.
Collapse
Affiliation(s)
- Geoffrey M Currie
- Charles Sturt University, Wagga Wagga, NSW, Australia; Baylor College of Medicine, Houston, TX.
| |
Collapse
|
16
|
Currie G, Barry K. ChatGPT in Nuclear Medicine Education. J Nucl Med Technol 2023; 51:247-254. [PMID: 37433676 DOI: 10.2967/jnmt.123.265844] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Revised: 05/13/2023] [Indexed: 07/13/2023] Open
Abstract
Academic integrity has been challenged by artificial intelligence algorithms in teaching institutions, including those providing nuclear medicine training. The GPT 3.5-powered ChatGPT chatbot released in late November 2022 has emerged as an immediate threat to academic and scientific writing. Methods: Both examinations and written assignments for nuclear medicine courses were tested using ChatGPT. Included was a mix of core theory subjects offered in the second and third years of the nuclear medicine science course. Long-answer-style questions (8 subjects) and calculation-style questions (2 subjects) were included for examinations. ChatGPT was also used to produce responses to authentic writing tasks (6 subjects). ChatGPT responses were evaluated by Turnitin plagiarism-detection software for similarity and artificial intelligence scores, scored against standardized rubrics, and compared with the mean performance of student cohorts. Results: ChatGPT powered by GPT 3.5 performed poorly in the 2 calculation examinations (overall, 31.7% compared with 67.3% for students), with particularly poor performance in complex-style questions. ChatGPT failed each of 6 written tasks (overall, 38.9% compared with 67.2% for students), with worsening performance corresponding to increasing writing and research expectations in the third year. In the 8 examinations, ChatGPT performed better than students for general or early subjects but poorly for advanced and specific subjects (overall, 51% compared with 57.4% for students). Conclusion: Although ChatGPT poses a risk to academic integrity, its usefulness as a cheating tool can be constrained by higher-order taxonomies. Unfortunately, the constraints to higher-order learning and skill development also undermine potential applications of ChatGPT for enhancing learning. There are several potential applications of ChatGPT for teaching nuclear medicine students.
Collapse
Affiliation(s)
- Geoffrey Currie
- Charles Sturt University, Wagga Wagga, New South Wales, Australia; and
| | - Kym Barry
- Charles Sturt University, Port Macquarie, New South Wales, Australia
| |
Collapse
|
17
|
Zamora-Mendoza BN, Sandoval-Flores H, Rodríguez-Aguilar M, Jiménez-González C, Alcántara-Quintana LE, Berumen-Rodríguez AA, Flores-Ramírez R. Determination of global chemical patterns in exhaled breath for the discrimination of lung damage in postCOVID patients using olfactory technology. Talanta 2023; 256:124299. [PMID: 36696734 DOI: 10.1016/j.talanta.2023.124299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Revised: 01/18/2023] [Accepted: 01/20/2023] [Indexed: 01/21/2023]
Abstract
The objective of this work was to evaluate the use of an electronic nose and chemometric analysis to discriminate global patterns of volatile organic compounds (VOCs) in breath of postCOVID syndrome patients with pulmonary sequelae. A cross-sectional study was performed in two groups, the group 1 were subjects recovered from COVID-19 without lung damage and the group 2 were subjects recovered from COVID-19 with impaired lung function. The VOCs analysis was executed using a Cyranose 320 electronic nose with 32 sensors, applying principal component analysis (PCA), Partial Least Square-Discriminant Analysis, random forest, canonical discriminant analysis (CAP) and the diagnostic power of the test was evaluated using the ROC (Receiver Operating Characteristic) curve. A total of 228 participants were obtained, for the postCOVID group there are 157 and 71 for the control group, the chemometric analysis results indicate in the PCA an 84% explanation of the variability between the groups, the PLS-DA indicates an observable separation between the groups and 10 sensors related to this separation, by random forest, a classification error was obtained for the control group of 0.090 and for the postCOVID group of 0.088 correct classification. The CAP model showed 83.8% of correct classification and the external validation of the model showed 80.1% of correct classification. Sensitivity and specificity reached 88.9% (73.9%-96.9%) and 96.9% (83.7%-99.9%) respectively. It is considered that this technology can be used to establish the starting point in the evaluation of lung damage in postCOVID patients with pulmonary sequelae.
Collapse
Affiliation(s)
- Blanca Nohemí Zamora-Mendoza
- Faculty of Medicine-Center for Applied Research on Environment and Health (CIAAS), Autonomous University of San Luis Potosí, Avenida Sierra Leona No. 550, CP 78210, Colonia Lomas Segunda Sección, San Luis Potosí, Mexico
| | - Hannia Sandoval-Flores
- Faculty of Medicine-Center for Applied Research on Environment and Health (CIAAS), Autonomous University of San Luis Potosí, Avenida Sierra Leona No. 550, CP 78210, Colonia Lomas Segunda Sección, San Luis Potosí, Mexico
| | | | - Carlos Jiménez-González
- Faculty of Medicine-Center for Applied Research on Environment and Health (CIAAS), Autonomous University of San Luis Potosí, Avenida Sierra Leona No. 550, CP 78210, Colonia Lomas Segunda Sección, San Luis Potosí, Mexico
| | - Luz Eugenia Alcántara-Quintana
- CONACYT Research Fellow, Coordination for Innovation and Application of Science and Technology (CIACYT), Autonomous University of San Luis Potosí, Avenida Sierra Leona No. 550, CP 78210, Colonia Lomas Segunda Sección, San Luis Potosí, Mexico
| | - Alejandra Abigail Berumen-Rodríguez
- Faculty of Medicine-Center for Applied Research on Environment and Health (CIAAS), Autonomous University of San Luis Potosí, Avenida Sierra Leona No. 550, CP 78210, Colonia Lomas Segunda Sección, San Luis Potosí, Mexico
| | - Rogelio Flores-Ramírez
- CONACYT Research Fellow, Coordination for Innovation and Application of Science and Technology (CIACYT), Autonomous University of San Luis Potosí, Avenida Sierra Leona No. 550, CP 78210, Colonia Lomas Segunda Sección, San Luis Potosí, Mexico.
| |
Collapse
|
18
|
Currie GM, Rohren EM. Radiation Dosimetry, Artificial Intelligence and Digital Twins: Old Dog, New Tricks. Semin Nucl Med 2023; 53:457-466. [PMID: 36379728 DOI: 10.1053/j.semnuclmed.2022.10.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Accepted: 10/28/2022] [Indexed: 11/14/2022]
Abstract
Developments in artificial intelligence, particularly convolutional neural networks and deep learning, have the potential for problem solving that has previously confounded human intelligence. Accurate prediction of radiation dosimetry pre-treatment with scope to adjust dosing for optimal target and non-target tissue doses is consistent with striving for improved the outcomes of precision medicine. The combination of artificial intelligence and production of digital twins could provide an avenue for an individualised therapy doses and enhanced outcomes in theranostics. While there are barriers to overcome, the maturity of individual technologies (i.e. radiation dosimetry, artificial intelligence, theranostics and digital twins) places these approaches within reach.
Collapse
Affiliation(s)
- Geoffrey M Currie
- Charles Sturt University, NSW, Australia; Baylor College of Medicine, TX.
| | - Eric M Rohren
- Charles Sturt University, NSW, Australia; Baylor College of Medicine, TX
| |
Collapse
|
19
|
Currie GM. Editorial: Next Generation Technologists for Next Generation Technology. Radiography (Lond) 2023; 29:625-626. [PMID: 37088068 DOI: 10.1016/j.radi.2023.04.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
Affiliation(s)
- G M Currie
- School of Dentistry & Medical Sciences, Charles Sturt University, Wagga Wagga, Australia; Baylor College of Medicine, Texas, USA.
| |
Collapse
|
20
|
Koetzier LR, Mastrodicasa D, Szczykutowicz TP, van der Werf NR, Wang AS, Sandfort V, van der Molen AJ, Fleischmann D, Willemink MJ. Deep Learning Image Reconstruction for CT: Technical Principles and Clinical Prospects. Radiology 2023; 306:e221257. [PMID: 36719287 PMCID: PMC9968777 DOI: 10.1148/radiol.221257] [Citation(s) in RCA: 115] [Impact Index Per Article: 57.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2022] [Revised: 09/26/2022] [Accepted: 10/13/2022] [Indexed: 02/01/2023]
Abstract
Filtered back projection (FBP) has been the standard CT image reconstruction method for 4 decades. A simple, fast, and reliable technique, FBP has delivered high-quality images in several clinical applications. However, with faster and more advanced CT scanners, FBP has become increasingly obsolete. Higher image noise and more artifacts are especially noticeable in lower-dose CT imaging using FBP. This performance gap was partly addressed by model-based iterative reconstruction (MBIR). Yet, its "plastic" image appearance and long reconstruction times have limited widespread application. Hybrid iterative reconstruction partially addressed these limitations by blending FBP with MBIR and is currently the state-of-the-art reconstruction technique. In the past 5 years, deep learning reconstruction (DLR) techniques have become increasingly popular. DLR uses artificial intelligence to reconstruct high-quality images from lower-dose CT faster than MBIR. However, the performance of DLR algorithms relies on the quality of data used for model training. Higher-quality training data will become available with photon-counting CT scanners. At the same time, spectral data would greatly benefit from the computational abilities of DLR. This review presents an overview of the principles, technical approaches, and clinical applications of DLR, including metal artifact reduction algorithms. In addition, emerging applications and prospects are discussed.
Collapse
Affiliation(s)
| | | | - Timothy P. Szczykutowicz
- From the Department of Radiology (L.R.K., D.M., A.S.W., V.S., D.F.,
M.J.W.) and Stanford Cardiovascular Institute (D.M., D.F., M.J.W.), Stanford
University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5105;
Department of Radiology, University of Wisconsin–Madison, School of
Medicine and Public Health, Madison, Wis (T.P.S.); Department of Radiology,
Erasmus Medical Center, Rotterdam, the Netherlands (N.R.v.d.W.); Clinical
Science Western Europe, Philips Healthcare, Best, the Netherlands (N.R.v.d.W.);
and Department of Radiology, Leiden University Medical Center, Leiden, the
Netherlands (A.J.v.d.M.)
| | - Niels R. van der Werf
- From the Department of Radiology (L.R.K., D.M., A.S.W., V.S., D.F.,
M.J.W.) and Stanford Cardiovascular Institute (D.M., D.F., M.J.W.), Stanford
University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5105;
Department of Radiology, University of Wisconsin–Madison, School of
Medicine and Public Health, Madison, Wis (T.P.S.); Department of Radiology,
Erasmus Medical Center, Rotterdam, the Netherlands (N.R.v.d.W.); Clinical
Science Western Europe, Philips Healthcare, Best, the Netherlands (N.R.v.d.W.);
and Department of Radiology, Leiden University Medical Center, Leiden, the
Netherlands (A.J.v.d.M.)
| | - Adam S. Wang
- From the Department of Radiology (L.R.K., D.M., A.S.W., V.S., D.F.,
M.J.W.) and Stanford Cardiovascular Institute (D.M., D.F., M.J.W.), Stanford
University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5105;
Department of Radiology, University of Wisconsin–Madison, School of
Medicine and Public Health, Madison, Wis (T.P.S.); Department of Radiology,
Erasmus Medical Center, Rotterdam, the Netherlands (N.R.v.d.W.); Clinical
Science Western Europe, Philips Healthcare, Best, the Netherlands (N.R.v.d.W.);
and Department of Radiology, Leiden University Medical Center, Leiden, the
Netherlands (A.J.v.d.M.)
| | - Veit Sandfort
- From the Department of Radiology (L.R.K., D.M., A.S.W., V.S., D.F.,
M.J.W.) and Stanford Cardiovascular Institute (D.M., D.F., M.J.W.), Stanford
University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5105;
Department of Radiology, University of Wisconsin–Madison, School of
Medicine and Public Health, Madison, Wis (T.P.S.); Department of Radiology,
Erasmus Medical Center, Rotterdam, the Netherlands (N.R.v.d.W.); Clinical
Science Western Europe, Philips Healthcare, Best, the Netherlands (N.R.v.d.W.);
and Department of Radiology, Leiden University Medical Center, Leiden, the
Netherlands (A.J.v.d.M.)
| | - Aart J. van der Molen
- From the Department of Radiology (L.R.K., D.M., A.S.W., V.S., D.F.,
M.J.W.) and Stanford Cardiovascular Institute (D.M., D.F., M.J.W.), Stanford
University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5105;
Department of Radiology, University of Wisconsin–Madison, School of
Medicine and Public Health, Madison, Wis (T.P.S.); Department of Radiology,
Erasmus Medical Center, Rotterdam, the Netherlands (N.R.v.d.W.); Clinical
Science Western Europe, Philips Healthcare, Best, the Netherlands (N.R.v.d.W.);
and Department of Radiology, Leiden University Medical Center, Leiden, the
Netherlands (A.J.v.d.M.)
| | - Dominik Fleischmann
- From the Department of Radiology (L.R.K., D.M., A.S.W., V.S., D.F.,
M.J.W.) and Stanford Cardiovascular Institute (D.M., D.F., M.J.W.), Stanford
University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5105;
Department of Radiology, University of Wisconsin–Madison, School of
Medicine and Public Health, Madison, Wis (T.P.S.); Department of Radiology,
Erasmus Medical Center, Rotterdam, the Netherlands (N.R.v.d.W.); Clinical
Science Western Europe, Philips Healthcare, Best, the Netherlands (N.R.v.d.W.);
and Department of Radiology, Leiden University Medical Center, Leiden, the
Netherlands (A.J.v.d.M.)
| | - Martin J. Willemink
- From the Department of Radiology (L.R.K., D.M., A.S.W., V.S., D.F.,
M.J.W.) and Stanford Cardiovascular Institute (D.M., D.F., M.J.W.), Stanford
University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5105;
Department of Radiology, University of Wisconsin–Madison, School of
Medicine and Public Health, Madison, Wis (T.P.S.); Department of Radiology,
Erasmus Medical Center, Rotterdam, the Netherlands (N.R.v.d.W.); Clinical
Science Western Europe, Philips Healthcare, Best, the Netherlands (N.R.v.d.W.);
and Department of Radiology, Leiden University Medical Center, Leiden, the
Netherlands (A.J.v.d.M.)
| |
Collapse
|
21
|
Currie G, Hawk KE, Rohren E. The transformational potential of molecular radiomics. J Med Radiat Sci 2022; 70 Suppl 2:77-88. [PMID: 36238997 PMCID: PMC10122929 DOI: 10.1002/jmrs.626] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2022] [Accepted: 09/28/2022] [Indexed: 11/06/2022] Open
Abstract
Conventional radiomics in nuclear medicine involve hand-crafted and computer-assisted regions of interest. Recent developments in artificial intelligence (AI) have seen the emergence of AI-augmented segmentation and extraction of lower order traditional radiomic features. Deep learning (DL) affords the opportunity to extract abstract radiomic features directly from input tensors (images) without the need for segmentation. These fourth-order, high dimensional radiomics produce deep radiomics and are well suited to the data density associated with the molecular nature of hybrid imaging. Molecular radiomics and deep molecular radiomics provide insights beyond images and quantitation typical of semantic reporting. While the application of molecular radiomics using hand-crafted and computer-generated features is integrated into decision-making in nuclear medicine, the acceptance of deep molecular radiomics is less universal. This manuscript aims to provide an understanding of the language and principles associated with radiomics and deep radiomics in nuclear medicine.
Collapse
Affiliation(s)
- Geoffrey Currie
- School of Dentistry and Medical Science, Charles Sturt University, Wagga Wagga, New South Wales, Australia.,Department of Radiology, Baylor College of Medicine, Houston, Texas, USA
| | - K Elizabeth Hawk
- School of Medicine, Stanford University, Stanford, California, USA.,Department of Radiology, University of California San Diego, San Diego, California, USA
| | - Eric Rohren
- School of Dentistry and Medical Science, Charles Sturt University, Wagga Wagga, New South Wales, Australia.,Department of Radiology, Baylor College of Medicine, Houston, Texas, USA
| |
Collapse
|
22
|
Giansanti D. The Regulation of Artificial Intelligence in Digital Radiology in the Scientific Literature: A Narrative Review of Reviews. Healthcare (Basel) 2022; 10:1824. [PMID: 36292270 PMCID: PMC9601605 DOI: 10.3390/healthcare10101824] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Revised: 09/14/2022] [Accepted: 09/20/2022] [Indexed: 09/05/2023] Open
Abstract
Today, there is growing interest in artificial intelligence (AI) in the field of digital radiology (DR). This is also due to the push that has been applied in this sector due to the pandemic. Many studies are devoted to the challenges of integration in the health domain. One of the most important challenges is that of regulations. This study conducted a narrative review of reviews on the international approach to the regulation of AI in DR. The design of the study was based on: (I) An overview on Scopus and Pubmed (II) A qualification and eligibility process based on a standardized checklist and a scoring system. The results have highlighted an international approach to the regulation of these systems classified as "software as medical devices (SaMD)" arranged into: ethical issues, international regulatory framework, and bottlenecks of the legal issues. Several recommendations emerge from the analysis. They are all based on fundamental pillars: (a) The need to overcome a differentiated approach between countries. (b) The need for greater transparency and publicity of information both for SaMDs as a whole and for the algorithms and test patterns. (c) The need for an interdisciplinary approach that avoids bias (including demographic) in algorithms and test data. (d) The need to reduce some limits/gaps of the scientific literature production that do not cover the international approach.
Collapse
|
23
|
Sathekge MM, Bouchelouche K. Letter from the Editors. Semin Nucl Med 2022; 52:403-405. [PMID: 35690428 DOI: 10.1053/j.semnuclmed.2022.04.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
24
|
Giansanti D, Di Basilio F. The Artificial Intelligence in Digital Radiology: Part 1: The Challenges, Acceptance and Consensus. Healthcare (Basel) 2022; 10:509. [PMID: 35326987 PMCID: PMC8949694 DOI: 10.3390/healthcare10030509] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2021] [Revised: 03/03/2022] [Accepted: 03/08/2022] [Indexed: 12/27/2022] Open
Abstract
Artificial intelligence is having important developments in the world of digital radiology also thanks to the boost given to the research sector by the COVID-19 pandemic. In the last two years, there was an important development of studies focused on both challenges and acceptance and consensus in the field of Artificial Intelligence. The challenges and acceptance and consensus are two strategic aspects in the development and integration of technologies in the health domain. The study conducted two narrative reviews by means of two parallel points of view to take stock both on the ongoing challenges and on initiatives conducted to face the acceptance and consensus in this area. The methodology of the review was based on: (I) search of PubMed and Scopus and (II) an eligibility assessment, using parameters with 5 levels of score. The results have: (a) highlighted and categorized the important challenges in place. (b) Illustrated the different types of studies conducted through original questionnaires. The study suggests for future research based on questionnaires a better calibration and inclusion of the challenges in place together with validation and administration paths at an international level.
Collapse
|